Ozempic is approved by the FDA for adults with type 2 diabetes to lower blood sugar, along with diet and exercise, reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who also have heart disease, and lower the risk of worsening kidney disease, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults with type 2 diabetes who also have chronic kidney disease
Atomoxetine, a norepinephrine reuptake inhibitor, does not compete with GLP-1 receptor activity, making it a generally safe choice for patients using semaglutide
Patient Questions dashboard/Patient Questions on EdenRx
These datasets include: in vivo data for the mouse studies and encompass metabolic, biochemical and histological data/images
If yes, your follicles may simply be reacting to reduced resources